{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:45:07Z","timestamp":1793270707709,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007437","name":"TrygFonden","doi-asserted-by":"publisher","award":["148727"],"award-info":[{"award-number":["148727"]}],"id":[{"id":"10.13039\/501100007437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","award":["0134-00066B"],"award-info":[{"award-number":["0134-00066B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","award":["A6622"],"award-info":[{"award-number":["A6622"]}],"id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia spectrum disorders cause suffering for patients, relatives, and the surrounding society. Paranoid ideations, encompassing ideas of social reference and manifest persecutory delusions, are among the most frequent symptoms in this population and a cause of significant distress. Recent meta-analyses of cognitive behavioral therapy (CBT) for psychosis show small to moderate effect sizes in reducing paranoid ideations. Virtual reality-based CBT (VR-CBT) could improve therapy efficacy as exposure and behavioral experiments in VR can be optimized, individualized, and carried out in a safe environment. Few VR-CBT studies exist for paranoid ideations and there is a need for large-scale, methodologically rigorous trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study is a randomized, assessor-blinded parallel-groups multi-center superiority clinical trial, fulfilling the CONSORT criteria for non-pharmacological treatment. A total of 256 patients diagnosed with schizophrenia spectrum disorder, including schizotypal disorder (ICD-10 F20-29), will be allocated to either 10 sessions of symptom-specific CBT-VR plus treatment as usual\u2014versus 10 sessions of standard symptom-specific CBT for paranoid ideations (CBT) plus treatment as usual. All participants will be assessed at baseline, treatment end (3 months post baseline), and then 9 months post baseline. A stratified block-randomization with concealed randomization sequence will be conducted. Independent assessors blinded to the treatment will evaluate the outcome. Analysis of outcome will be carried out with the intention to treat principles.<\/jats:p>\n                    <jats:p>The primary outcome is ideas of social reference measured with Green Paranoid Thought Scale Part A (GPTS-A) at the cessation of treatment at 3 months post baseline. Secondary outcomes are ideas of persecution (GPTS-B), Social Interaction Anxiety Scale (SIAS), Personal and Social Performance scale (PSP), Safety Behavior Questionnaire (SBQ), and CANTAB Emotion Recognition Task.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The trial will elucidate whether VR-CBT can enhance therapy efficacy for paranoid ideations. Additionally, Trial findings will provide evidence on the effectiveness and cost-effectiveness of VR-CBT for paranoid ideations that can guide the possible dissemination and implementation into clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04902066\">NCT04902066<\/jats:ext-link>\n                      . Initial release April 9th, 2021.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-022-06614-0","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:03:09Z","timestamp":1660539789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Face Your Fears: Virtual reality-based cognitive behavioral therapy (VR-CBT) versus standard CBT for paranoid ideations in patients with schizophrenia spectrum disorders: a randomized clinical trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9481-1554","authenticated-orcid":false,"given":"U. N.","family":"Jeppesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Due","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mariegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pinkham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Veling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. B.","family":"Glenth\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"4","key":"6614_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","volume":"15","author":"W R\u00f6ssler","year":"2005","unstructured":"R\u00f6ssler W, Salize HJ, Van Os J, Riecher-R\u00f6ssler A. Size of burden of schizophrenia and psychotic disorders. Eur Neuropsychopharmacol. 2005;15(4):399\u2013409 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15925493\/ [cited 23 Jul 2021].","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"6614_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD 2019 Mental Disorders Collaborators","year":"2022","unstructured":"GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9(2):137\u201350 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35026139\/ [cited 7 Mar 2022].","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"6614_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1017\/S0033291707001638","volume":"38","author":"CEL Green","year":"2008","unstructured":"Green CEL, Freeman D, Kuipers E, Bebbington P, Fowler D, Dunn G, et al. Measuring ideas of persecution and social reference: The Green et al. Paranoid Thought Scales (GPTS). Psychol Med. 2008;38(1):101\u201311.","journal-title":"Psychol Med"},{"issue":"4","key":"6614_CR4","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1017\/S0033291700011910","volume":"16","author":"N Sartorius","year":"1986","unstructured":"Sartorius N, Jablensky A, Korten A, Ernberg G, Anker M, Cooper JE, et al. Early manifestations and first-contact incidence of schizophrenia in different cultures: a preliminary report on the initial evaluation phase of the WHO Collaborative Study on Determinants of Outcome of Severe Mental Disorders. Psychol Med. 1986;16(4):909\u201328 Available from: https:\/\/www-cambridge-org.ep.fjernadgang.kb.dk\/core\/journals\/psychological-medicine\/article\/early-manifestations-and-firstcontact-incidence-of-schizophrenia-in-different-cultures-a-preliminary-report-on-the-initial-evaluation-phase-of-the-who-collaborative-study-on-determinants-of-outcome-of-severe-mental-disorders\/3C7A646CA9EC43AC75057AA05F25FB29 [cited 16 Mar 2022].","journal-title":"Psychol Med"},{"issue":"4","key":"6614_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.cpr.2006.10.004","volume":"27","author":"D Freeman","year":"2007","unstructured":"Freeman D. Suspicious minds: the psychology of persecutory delusions. Clin Psychol Rev. 2007;27(4):425\u201357.","journal-title":"Clin Psychol Rev"},{"key":"6614_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1192\/bjp.186.5.427","volume":"186","author":"D Freeman","year":"2005","unstructured":"Freeman D, Garety PA, Bebbington PE, Smith B, Rollinson R, Fowler D, et al. Psychological investigation of the structure of paranoia in a non-clinical population. Br J Psychiatry. 2005;186:427\u201335.","journal-title":"Br J Psychiatry"},{"issue":"1\u20132","key":"6614_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.psychres.2005.07.007","volume":"137","author":"M Startup","year":"2005","unstructured":"Startup M, Startup S. On two kinds of delusion of reference. Psychiatry Res. 2005;137(1\u20132):87\u201392.","journal-title":"Psychiatry Res"},{"key":"6614_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.schres.2016.10.030","volume":"182","author":"RS Wils","year":"2017","unstructured":"Wils RS, Gotfredsen DR, Hjorth\u00f8j C, Austin SF, Albert N, Secher RG, et al. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis. Schizophr Res. 2017;182:42\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28277310\/ [cited 23 Jul 2021].","journal-title":"Schizophr Res"},{"issue":"1\u20132","key":"6614_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin SF, Mors O, Budtz-J\u00f8rgensen E, Secher RG, Hjorth\u00f8j CR, Bertelsen M, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: A 10year follow-up study in the OPUS cohort. Schizophr Res. 2015;168(1\u20132):84\u201391 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26265299\/ [cited 23 Jul 2021].","journal-title":"Schizophr Res"},{"issue":"12","key":"6614_CR10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1017\/S0033291717000563","volume":"47","author":"DR Gotfredsen","year":"2017","unstructured":"Gotfredsen DR, Wils RS, Hjorth\u00f8j C, Austin SF, Albert N, Secher RG, et al. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up. Psychol Med. 2017;47(12):2118\u201329 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28382874\/ [cited 23 Jul 2021].","journal-title":"Psychol Med"},{"issue":"6","key":"6614_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/13546800701566686","volume":"12","author":"M Moutoussis","year":"2007","unstructured":"Moutoussis M, Williams J, Dayan P, Bentall RP. Persecutory delusions and the conditioned avoidance paradigm: towards an integration of the psychology and biology of paranoia. Cogn Neuropsychiatry. 2007;12(6):495\u2013510 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17978936\/ [cited 16 Mar 2022].","journal-title":"Cogn Neuropsychiatry"},{"issue":"1","key":"6614_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0920-9964(00)00024-4","volume":"46","author":"EM Macdonald","year":"2000","unstructured":"Macdonald EM, Hayes RL, Baglioni AJ Jr. The quantity and quality of the social networks of young people with early psychosis compared with closely matched controls. Schizophr Res. 2000;46(1):25\u201330 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11099882\/ [cited 23 Jul 2021].","journal-title":"Schizophr Res"},{"key":"6614_CR13","unstructured":"Loneliness and the psychosis continuum: a meta-analysis on positive psychot...: EBSCOhost. Available from: https:\/\/web-s-ebscohost-com.ep.fjernadgang.kb.dk\/ehost\/pdfviewer\/pdfviewer?vid=0&sid=a76aa9c1-434e-4be6-ade6-5e4c833167b5%40redis. [cited 24 Mar 2022]."},{"issue":"9","key":"6614_CR14","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1177\/0004867412449060","volume":"46","author":"HJ Stain","year":"2012","unstructured":"Stain HJ, Galletly CA, Clark S, Wilson J, Killen EA, Anthes L, et al. Understanding the social costs of psychosis: the experience of adults affected by psychosis identified within the second Australian National Survey of Psychosis. Aust N Z J Psychiatry. 2012;46(9):879\u201389 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22645395\/ [cited 7 Mar 2022].","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"6614_CR15","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1176\/appi.ajp.2013.13081159","volume":"171","author":"DT Turner","year":"2014","unstructured":"Turner DT, Van Der Gaag M, Karyotaki E, Cuijpers P. Psychological interventions for psychosis: A meta-analysis of comparative outcome studies. Am J Psychiatry. 2014;171(5):523\u201338.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"6614_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1192\/bjp.bp.112.116285","volume":"204","author":"S Jauhar","year":"2014","unstructured":"Jauhar S, McKenna PJ, Radua J, Fung E, Salvador R, Laws KR. Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias. Br J Psychiatry. 2014;204(1):20\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24385461\/ [cited 28 Feb 2022].","journal-title":"Br J Psychiatry"},{"issue":"3","key":"6614_CR17","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/wps.20577","volume":"17","author":"I Bighelli","year":"2018","unstructured":"Bighelli I, Salanti G, Huhn M, Schneider-Thoma J, Krause M, Reitmeir C, et al. Psychological interventions to reduce positive symptoms in schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2018;17(3):316\u201329 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30192101\/ [cited 27 Jan 2022].","journal-title":"World Psychiatry"},{"issue":"5","key":"6614_CR18","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/schbul\/sbaa045","volume":"46","author":"DT Turner","year":"2020","unstructured":"Turner DT, Burger S, Smit F, Valmaggia LR, van der Gaag M. What Constitutes Sufficient Evidence for Case Formulation-Driven CBT for Psychosis? Cumulative Meta-analysis of the Effect on Hallucinations and Delusions. Schizophr Bull. 2020;46(5):1072\u201385 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32221536\/ [cited 18 Mar 2022].","journal-title":"Schizophr Bull"},{"key":"6614_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.schres.2017.12.014","volume":"203","author":"TM Lincoln","year":"2019","unstructured":"Lincoln TM, Peters E. A systematic review and discussion of symptom specific cognitive behavioural approaches to delusions and hallucinations. Schizophr Res. 2019;203:66\u201379 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29352708\/ [cited 18 Mar 2022].","journal-title":"Schizophr Res"},{"issue":"3","key":"6614_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/schbul\/sbm114","volume":"34","author":"T Wykes","year":"2008","unstructured":"Wykes T, Steel C, Everitt B, Tarrier N. Cognitive behavior therapy for schizophrenia: Effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008;34(3):523\u201337.","journal-title":"Schizophr Bull"},{"issue":"1","key":"6614_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1192\/bjp.bp.115.176438","volume":"209","author":"D Freeman","year":"2016","unstructured":"Freeman D, Bradley J, Antley A, Bourke E, DeWeever N, Evans N, et al. Virtual reality in the treatment of persecutory delusions: randomised controlled experimental study testing how to reduce delusional conviction. Br J Psychiatry. 2016;209(1):62\u20137 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27151071\/ [cited 23 Jul 2021].","journal-title":"Br J Psychiatry"},{"issue":"3","key":"6614_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S2215-0366(18)30053-1","volume":"5","author":"RMCA Pot-Kolder","year":"2018","unstructured":"Pot-Kolder RMCA, Geraets CNW, Veling W, van Beilen M, Staring ABP, Gijsman HJ, et al. Virtual-reality-based cognitive behavioural therapy versus waiting list control for paranoid ideation and social avoidance in patients with psychotic disorders: a single-blind randomised controlled trial. Lancet Psychiatry. 2018;5(3):217\u201326. https:\/\/doi.org\/10.1016\/S2215-0366(18)30053-1.","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"6614_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2196\/17098","volume":"22","author":"R Pot-Kolder","year":"2020","unstructured":"Pot-Kolder R, Veling W, Geraets C, Lokkerbol J, Smit F, Jongeneel A, et al. Cost-effectiveness of virtual reality cognitive behavioral therapy for psychosis: Health-economic evaluation within a randomized controlled trial. J Med Internet Res. 2020;22(5):1\u201313.","journal-title":"J Med Internet Res"},{"issue":"9926","key":"6614_CR24","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S0140-6736(13)62246-1","volume":"383","author":"AP Morrison","year":"2014","unstructured":"Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, et al. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet. 2014;383(9926):1395\u2013403.","journal-title":"Lancet."},{"issue":"4","key":"6614_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1177\/0269881117695879","volume":"31","author":"KD Jakobsen","year":"2017","unstructured":"Jakobsen KD, Skyum E, Hashemi N, Schjerning O, Fink-Jensen A, Nielsen J. Antipsychotic treatment of schizotypy and schizotypal personality disorder: a systematic review. J Psychopharmacol. 2017;31(4):397\u2013405 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28347257\/ [cited 30 Mar 2022].","journal-title":"J Psychopharmacol"},{"issue":"7","key":"6614_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11920-014-0452-1","volume":"16","author":"DR Rosell","year":"2014","unstructured":"Rosell DR, Futterman SE, McMaster A, Siever LJ. Schizotypal personality disorder: a current review. Curr Psychiatry Rep. 2014;16(7):1\u20132 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24828284\/ [cited 30 Mar 2022].","journal-title":"Curr Psychiatry Rep"},{"key":"6614_CR27","unstructured":"Mental health services in the Capital Region of Denmark - information in English. Available from: https:\/\/www.psykiatri-regionh.dk\/english\/Sider\/default.aspx [cited 30 May 2022]."},{"key":"6614_CR28","unstructured":"English. Available from: https:\/\/aalborguh.rn.dk\/service\/english [cited 30 May 2022]."},{"key":"6614_CR29","doi-asserted-by":"crossref","unstructured":"Berkhof M, van der Stouwe ECD, Lestestuiver B, van\u2019t Hag E, van Grunsven R, de Jager J, et al. Virtual reality cognitive-behavioural therapy versus cognitive-behavioural therapy for paranoid delusions: a study protocol for a single-blind multi-Centre randomised controlled superiority trial. BMC Psychiatry. 2021;21(1) Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34635063\/ [cited 12 Apr 2022].","DOI":"10.1186\/s12888-021-03473-y"},{"key":"6614_CR30","doi-asserted-by":"crossref","unstructured":"Soll D, Fuchs R, Mehl S. Teaching Cognitive Behavior Therapy to Postgraduate Health Care Professionals in Times of COVID 19 - An Asynchronous Blended Learning Environment Proved to Be Non-inferior to In-Person Training. Front Psychol. 2021;12 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34646190\/ [cited 18 Mar 2022].","DOI":"10.3389\/fpsyg.2021.657234"},{"key":"6614_CR31","doi-asserted-by":"crossref","unstructured":"Vallis TM, Shaw BF, Dobson KS. The Cognitive Therapy Scale. Psychometric Properties. J Consult Clin Psychol. 1986;54(3):381\u2013385.","DOI":"10.1037\/0022-006X.54.3.381"},{"issue":"SUPPL. 51","key":"6614_CR32","doi-asserted-by":"publisher","first-page":"s63","DOI":"10.1192\/bjp.191.51.s63","volume":"51","author":"LR Valmaggia","year":"2007","unstructured":"Valmaggia LR, Freeman D, Green C, Garety P, Swapp D, Antley A, et al. Virtual reality and paranoid ideations in people with an \u201cat-risk mental state\u201d for psychosis. Br J Psychiatry Suppl. 2007;51(SUPPL. 51):s63\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18055940\/ [cited 23 Jul 2021].","journal-title":"Br J Psychiatry Suppl"},{"issue":"4","key":"6614_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0005-7967(97)10031-6","volume":"36","author":"RP Mattick","year":"1998","unstructured":"Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36(4):455\u201370 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9670605\/ [cited 23 Jul 2021].","journal-title":"Behav Res Ther"},{"issue":"1\u20132","key":"6614_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0920-9964(02)00376-6","volume":"63","author":"P Kingsep","year":"2003","unstructured":"Kingsep P, Nathan P, Castle D. Cognitive behavioural group treatment for social anxiety in schizophrenia. Schizophr Res. 2003;63(1\u20132):121\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12892866\/ [cited 12 Apr 2022].","journal-title":"Schizophr Res"},{"issue":"2","key":"6614_CR35","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.psychres.2007.11.012","volume":"161","author":"H Nasrallah","year":"2008","unstructured":"Nasrallah H, Morosini P, Gagnon DD. Reliability, validity and ability to detect change of the Personal and Social Performance scale in patients with stable schizophrenia. Psychiatry Res. 2008;161(2):213\u201324 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18848731\/ [cited 23 Jul 2021].","journal-title":"Psychiatry Res"},{"issue":"7","key":"6614_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1017\/S003329170100455X","volume":"31","author":"D Freeman","year":"2001","unstructured":"Freeman D, Garety PA, Kuipers E. Persecutory delusions: developing the understanding of belief maintenance and emotional distress. Psychol Med. 2001;31(7):1293\u2013306.","journal-title":"Psychol Med"},{"key":"6614_CR37","unstructured":"Computerized assessment in neuropsychiatry using CANTAB: discussion paper - PubMed. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1629849\/ [cited 23 Jul 2021]."},{"key":"6614_CR38","unstructured":"EQ-5D-5L \u2013 EQ-5D. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/ [cited 23 Jul 2021]."},{"issue":"1\u20132","key":"6614_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jad.2009.06.005","volume":"122","author":"EA Newnham","year":"2010","unstructured":"Newnham EA, Hooke GR, Page AC. Monitoring treatment response and outcomes using the World Health Organization\u2019s Wellbeing Index in psychiatric care. J Affect Disord. 2010;122(1\u20132):133\u20138 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/19592116\/ [cited 23 Jul 2021].","journal-title":"J Affect Disord"},{"issue":"7","key":"6614_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archpsyc.1990.01810190015002","volume":"47","author":"NC Andreasen","year":"1990","unstructured":"Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch Gen Psychiatry. 1990;47(7):615\u201321 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/2360855\/ [cited 23 Jul 2021].","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"6614_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.eurpsy.2015.01.014","volume":"30","author":"A Mucci","year":"2015","unstructured":"Mucci A, Galderisi S, Merlotti E, Rossi A, Rocca P, Bucci P, et al. The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia. Eur Psychiatry. 2015;30(5):641\u20137 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25758156\/ [cited 23 Jul 2021].","journal-title":"Eur Psychiatry"},{"issue":"22","key":"6614_CR42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"163","author":"D Addington","year":"1993","unstructured":"Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl. 1993;163(22):39\u201344 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/8110442\/ [cited 23 Jul 2021].","journal-title":"Br J Psychiatry Suppl"},{"issue":"4","key":"6614_CR43","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/sltb.12084","volume":"44","author":"BA Van Spijker","year":"2014","unstructured":"Van Spijker BA, Batterham PJ, Calear AL, Farrer L, Christensen H, Reynolds J, et al. The suicidal ideation attributes scale (SIDAS): Community-based validation study of a new scale for the measurement of suicidal ideation. Suicide Life Threat Behav. 2014;44(4):408\u201319 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24612048\/ [cited 23 Jul 2021].","journal-title":"Suicide Life Threat Behav"},{"issue":"4","key":"6614_CR44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/138161212799316064","volume":"18","author":"F Schultze-Lutter","year":"2012","unstructured":"Schultze-Lutter F, Ruhrmann S, Fusar-Poli P, Bechdolf A, G. Schimmelmann B, Klosterkotter J. Basic symptoms and the prediction of first-episode psychosis. Curr Pharm Des. 2012;18(4):351\u20137.","journal-title":"Curr Pharm Des"},{"issue":"1\u20133","key":"6614_CR45","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.schres.2012.12.010","volume":"144","author":"M van der Gaag","year":"2013","unstructured":"van der Gaag M, Sch\u00fctz C, Ten Napel A, Landa Y, Delespaul P, Bak M, et al. Development of the Davos assessment of cognitive biases scale (DACOBS). Schizophr Res. 2013;144(1\u20133):63\u201371 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23332365\/ [cited 23 Jul 2021].","journal-title":"Schizophr Res"},{"issue":"5","key":"6614_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3200\/JRLP.139.5.439-457","volume":"139","author":"A Luszczynska","year":"2005","unstructured":"Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439\u201357 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16285214\/ [cited 23 Jul 2021].","journal-title":"J Psychol"},{"issue":"3","key":"6614_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cognition.2008.07.001","volume":"108","author":"E Rosset","year":"2008","unstructured":"Rosset E. It\u2019s no accident: Our bias for intentional explanations. Cognition. 2008;108(3):771\u201380 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18692779\/ [cited 23 Jul 2021].","journal-title":"Cognition"},{"issue":"6684","key":"6614_CR48","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/30982","volume":"393","author":"R Adolphs","year":"1998","unstructured":"Adolphs R, Tranel D, Damasio AR. The human amygdala in social judgment. Nature. 1998;393(6684):470\u20134 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/9624002\/ [cited 23 Jul 2021].","journal-title":"Nature"},{"issue":"2\u20133","key":"6614_CR49","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0920-9964(00)00109-2","volume":"48","author":"TL Patterson","year":"2001","unstructured":"Patterson TL, Moscona S, McKibbin CL, Davidson K, Jeste DV. Social skills performance assessment among older patients with schizophrenia. Schizophr Res. 2001;48(2\u20133):351\u201360 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/11295387\/ [cited 23 Jul 2021].","journal-title":"Schizophr Res"},{"issue":"1","key":"6614_CR50","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1037\/1040-3590.4.1.26","volume":"4","author":"LR Goldberg","year":"1992","unstructured":"Goldberg LR. The Development of Markers for the Big-Five Factor Structure. Psychol Assess. 1992;4(1):26\u201342 Available from: https:\/\/psycnet.apa.org\/journals\/pas\/4\/1\/26 [cited 23 Jul 2021].","journal-title":"Psychol Assess"},{"key":"6614_CR51","doi-asserted-by":"crossref","unstructured":"Carr S, Hardy A, Fornells-Ambrojo M. The Trauma and Life Events (TALE) checklist: development of a tool for improving routine screening in people with psychosis. Eur J Psychotraumatol. 2018;9(1) Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30220986\/ [cited 23 Jul 2021].","DOI":"10.1080\/20008198.2018.1512265"},{"issue":"2","key":"6614_CR52","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1017\/S0033291719003155","volume":"51","author":"D Freeman","year":"2021","unstructured":"Freeman D, Loe BS, Kingdon D, Startup H, Molodynski A, Rosebrock L, et al. The revised Green et al., Paranoid Thoughts Scale (R-GPTS): Psychometric properties, severity ranges, and clinical cut-offs. Psychol Med. 2021;51(2):244\u201353.","journal-title":"Psychol Med"},{"issue":"3","key":"6614_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0149-7189(79)90094-6","volume":"2","author":"DL Larsen","year":"1979","unstructured":"Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD. Assessment of client\/patient satisfaction: development of a general scale. Eval Program Plann. 1979;2(3):197\u2013207 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10245370\/ [cited 2021 Jul 23].","journal-title":"Eval Program Plann"},{"key":"6614_CR54","unstructured":"Center for IT og Medicoteknologi. Available from: https:\/\/www.regionh.dk\/om-region-hovedstaden\/denAdministrativeRegion\/CIMT\/Sider\/default.aspx. [cited 25 Apr 2022]."},{"issue":"3","key":"6614_CR55","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1017\/S0033291717001945","volume":"48","author":"M Rus-Calafell","year":"2018","unstructured":"Rus-Calafell M, Garety P, Sason E, Craig TJK, Valmaggia LR. Virtual reality in the assessment and treatment of psychosis: a systematic review of its utility, acceptability and effectiveness. Psychol Med. 2018;48(3):362\u201391 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28735593\/ [cited 19 Jan 2022].","journal-title":"Psychol Med"},{"issue":"SUPPL. 2","key":"6614_CR56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4088\/JCP.13065su1.04","volume":"75","author":"AE Pinkham","year":"2014","unstructured":"Pinkham AE. Social cognition in schizophrenia. J Clin Psychiatry. 2014;75(SUPPL. 2):14\u20139 Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24919166\/ [cited 9 May 2022].","journal-title":"J Clin Psychiatry"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06614-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06614-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T10:25:46Z","timestamp":1675247146000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06614-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6614"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06614-0","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"16 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Committee on Health Research Ethics of the Capital Region Denmark (H-20048806), and the Danish Data Protection Agency (P-2020-823).Written informed consent will be obtained from all participants in the study, and participants have the right to withdraw from the study at any time and for any reason.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"This manuscript does not contain any individual person\u2019s data. Informed consent materials are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"658"}}